{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:42:31Z","timestamp":1777430551727,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.parkreldis.2018.06.017","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T05:57:27Z","timestamp":1529042247000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-1897","authenticated-orcid":false,"given":"Gon\u00e7alo S.","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-7938","authenticated-orcid":false,"given":"Filipe B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-5113","authenticated-orcid":false,"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.06.017_bib1","article-title":"Botulinum toxin type A therapy for cervical dystonia","volume":"12","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2018.06.017_bib2","article-title":"Botulinum toxin type B for cervical dystonia","volume":"5","author":"Marques","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2018.06.017_bib3","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","volume":"10","author":"Duarte","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.parkreldis.2018.06.017_bib4","first-page":"281","article-title":"Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Payment policy perspectives","volume":"6","author":"Govindarajan","year":"2016","journal-title":"Neurology: Clin. Pract."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.06.017_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"19","key":"10.1016\/j.parkreldis.2018.06.017_bib6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache report of the guideline development subcommittee of the american academy of neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.parkreldis.2018.06.017_bib7","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004004","article-title":"Placebo and nocebo responses in restless legs syndrome: a systematic review and meta-analysis","volume":"88","author":"Silva","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.06.017_bib8","series-title":"R: a Language and Environment for Statistical Computing","author":"Team","year":"2017"},{"issue":"7414","key":"10.1016\/j.parkreldis.2018.06.017_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"issue":"4","key":"10.1016\/j.parkreldis.2018.06.017_bib10","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1016\/j.ijcard.2013.05.068","article-title":"Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information","volume":"168","author":"Barron","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.parkreldis.2018.06.017_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/2047487314525531","article-title":"What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice","volume":"21","author":"Finegold","year":"2014","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.parkreldis.2018.06.017_bib12","series-title":"Placebo Interventions for all Clinical Conditions","author":"Hr\u00f3bjartsson","year":"2010"},{"issue":"3","key":"10.1016\/j.parkreldis.2018.06.017_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects","volume":"67","author":"McCambridge","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.parkreldis.2018.06.017_bib14","article-title":"Botulinum toxin for drooling in Parkinson's disease","volume":"10","author":"Hill","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2018.06.017_bib15","first-page":"445","article-title":"The Toronto western spasmodic Torticollis rating scale (TWSTRS): assessment of validity and inter-rater reliability","volume":"40","author":"Consky ES","year":"1990","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T18:23:20Z","timestamp":1545071000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018302761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"alternative-id":["S1353802018302761"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}